Literature DB >> 24900822

Thiazolocarboxamide Analogues as NAMPT Inhibitors.

Jean-Francois Brazeau1, Gerard Rosse2.   

Abstract

Entities:  

Year:  2014        PMID： 24900822      PMCID： PMC4027748          DOI： 10.1021/ml500046t

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  1 in total

Review 1.  The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer.

Authors:  Mara Gallí; Frédéric Van Gool; Anthony Rongvaux; Fabienne Andris; Oberdan Leo
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701
  1 in total
  2 in total

Review 1.  Epigenetic polypharmacology: A new frontier for epi-drug discovery.

Authors:  Daniela Tomaselli; Alessia Lucidi; Dante Rotili; Antonello Mai
Journal:  Med Res Rev       Date:  2019-06-20       Impact factor: 12.944

2.  Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery.

Authors:  Wei Chen; Guoqiang Dong; Ying Wu; Wannian Zhang; Chaoyu Miao; Chunquan Sheng
Journal:  ACS Med Chem Lett       Date:  2017-12-14       Impact factor: 4.345
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.